Skip to main content
Veterinary Medicines

Caninsulin® vet. 40 IU/ml, suspension for injection

Authorised
  • Insulin porcine

Product identification

Medicine name:
Caninsulin® vet. 40 IU/ml, suspension for injection
Caninsulin vet. 40 IU/ml injektioneste, suspensio koiralle ja kissalle
Active substance:
  • Insulin porcine
Target species:
  • Dog
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Insulin porcine
    40.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA10AC03
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:
  • Cartridge, 10 x 2.7 ml
  • Vial, 10 x 2,5 ml
  • Vial, 10 x 10 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
  • Oriola Sweden AB
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 31361
Date of authorisation status change:
Reference member state:
  • Sweden
Procedure number:
  • SE/V/0119/001
Concerned member states:
  • Estonia
  • Finland
  • Latvia
  • Norway

Documents

Summary of Product Characteristics

English (PDF)
Published on: 23/01/2024
Download
Finnish (PDF)
Published on: 7/02/2024

Package Leaflet

English (PDF)
Published on: 23/01/2024
Download
Finnish (PDF)
Published on: 7/02/2024

Labelling

English (PDF)
Published on: 23/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."